TinyGemsBreaks Archive - Page 81 of 151

MondayAug 14, 2023 12:51 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q2 2023 Results, Presents Updated Findings from Potentially Pivotal Study of Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced its financial results for the quarter ended June 30, 2023, provided a corporate update and reiterated upcoming milestones. “We are approaching the most important milestone to date since we launched CNS Pharma. We are just a few months away from reporting topline results from our Berubicin potentially pivotal study interim analysis and, although we do not know what the data looks like at this time, we remain hopeful as we also approach…

FridayAug 11, 2023 3:00 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Monitoring Developments in Commercial Vehicles Industry as Part of Overall Focus to Revolutionize Cross-Border Shipping

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company revolutionizing cross-border shipping by offering carriers increased growth opportunities and shippers with flexibility, visibility and simplicity, is closely monitoring speed limiter directives on commercial vehicles. “As a company heavily invested in the industry, such directives could impact its performance and service delivery,” a recent article reads. “The Federal Motor Carrier Safety Administration (‘FMCSA’) proposed a rule that would mandate speed limiters for most commercial vehicles. While the exact speed has not been confirmed, safety groups have proposed a 60 mph limit for heavy-duty trucks. This is not the first time such a…

FridayAug 11, 2023 2:12 pm

TinyGemsBreaks – GEMXX Corporation (GEMZ) Reports on Form 1A Qualification, Shares Update

GEMXX (OTC: GEMZ), a leader in the Ammolite gemstone mine-to-market segment, has announced full qualification of Tier 1, Form 1A registration statement and has released an update on certain achievements. According to the announcement, GEMXX’s Form 1-A to raise up to $6 million is fully qualified. In addition, company officials noted that the company is working with several parties that are interested in participating in the Regulation-A financing; funds from that financing will be used for Ammolite mining expansion, increased production and diversification of operations. The company’s M&A team is also focused on further strengthening the business through strategic partnerships and…

FridayAug 11, 2023 1:49 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) ‘Secret Agent Man’ Robot Security Guard Featured in Fox News Report

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has been spotlighted in a recent Fox News report. The Aug. 9, 2023, report noted that Crocker Park, an Ohio shopping center, is integrating cutting-edge AI tech by deploying a 400-pound robot security guard to further ensure safety. Crocker Park VP of marketing Stacie Schmidt called the Knightscope ASR a “secret agent man” (“SAM”), noting that the robot was the newest member of the mall’s security team. Crocker Park is an open-air shopping mall in Westlake, Ohio, a suburban town located about 15…

ThursdayAug 10, 2023 1:28 pm

TinyGemsBreaks – Genprex Inc. (NASDAQ: GNPX) Granted FDA Orphan Drug Designation for REQORSA(R) for Patients with SCLC

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that the United States Food and Drug Administration (“FDA”) has granted Orphan Drug Designation (“ODD”) to the company’s lead drug candidate, REQORSA(R) Immunogene Therapy (quratusugene ozeplasmid), for the treatment of small cell lung cancer (“SCLC”). In addition to ODD for the treatment of SCLC, in June 2023, the FDA granted Fast Track Designation (“FTD”) for REQORSA Immunogene Therapy, in combination with Genentech Inc.’s Tecentriq(R) in patients with extensive-stage small cell lung cancer (“ES-SCLC”) who did not develop tumor progression…

ThursdayAug 10, 2023 1:20 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Commences Class 3 Vehicle Production at Tunica Facility

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the start of vehicle production at its Tunica, Mississippi, assembly plant for the Mullen THREE, Class 3 EV truck with first customer deliveries on track to begin in August and September. According to the update, the company will be gradually ramping up the production rate over the course of September through December, with Class 3 production capacity at the Tunica facility currently planned for 3,000 Class 3 vehicles per year. To date, Mullen has received $79 million in purchase orders for 1,250 Mullen THREE, Class 3 EV trucks…

ThursdayAug 10, 2023 11:32 am

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces Second Deployment to Chicago, Sends K5 ASR to Patrol Urban Development Parking Space

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, announced that one of its K5 ASRs is now patrolling the parking lot of a mixed-use facility in Chicago. The deployment, the latest in a growing number of contracts for the company, is with a property management group. The parking lot provides parking for both retail and professional tenants. According to the company, this is the second deployment in the Windy City and is located in an area where crime, trespassing, vehicle break-ins, and catalytic converter thefts are rising. Knightscope’s ASRs support and enhances security…

ThursdayAug 10, 2023 11:12 am

TinyGemsBreaks – GEMXX Corporation (GEMZ) Releases Quarterly Financial Report, Provides Corporate Update

GEMXX (OTC: GEMZ), a leader in the Ammolite gemstone mine-to-market segment, is reporting positive revenues for the quarter and providing an update on significant company achievements for the quarter. Highlights of the report include shares issued and outstanding totaling 96,866,845 with the quarter’s account receivables reaching $690,310, up from $318,390 in the same quarter last year. Net Income reached $182,992.00 compared to $126,360 in the previous quarter with total long-term liabilities being reported as zero, down from $226,759 last year. GEMXX total assets came in at total assets totaled $18,610,757, up from $1,226,354. “The company continues to build a solid…

WednesdayAug 09, 2023 1:29 pm

TinyGemsBreaks – GEMXX Corp. (GEMZ) Complements Ammolite Production with Strategic Purchase

GEMXX (OTC: GEMZ), a leader in the Ammolite Gems mine-to-market segment, recently announced its acquisition of a 50% interest in the Canadian exploration company Crazy Horse Mining Inc. (“CHMI”). CHMI assets include 100% interest in two gold projects, Snow Creek and Rosella Creek, covering more than 700 acres. “The acquisition of the Snow Creek and Rosella Creek gold asset portfolio enhances the company’s long-term asset expansion plan and helps to de-risk revenues, but most importantly, it complements our Ammolite production with the world’s most sought-after commodity,” said Jay Maull, GEMXX’s chief executive officer. “This will provide GEMXX with a significant…

WednesdayAug 09, 2023 12:29 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Results from Human Oral Nicotine Study Evaluating DehydraTECH(TM)-Nicotine

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting results from its 2023 human oral nicotine study NIC-H22-1. The study compared Lexaria’s DehydraTECH(TM)-Nicotine tobacco-free pouch to two world-leading brands: ZYN(R) and on!(R) ZYN(R) is from Swedish Match and on! comes from Altria Group Inc. subsidiary Helix Innovations LLC. According to the report, DehydraTECH-Nicotine reached maximum blood saturation levels faster than either of the two other brands. In addition, superior subjective performance characteristics were observed in the study. Specifically, Lexaria’s oral nicotine pouch was significantly faster in the median time required to reach comparable maximum nicotine concentrations…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks